Skip to content

Study on health benefits of the broccoli Super Sprout

Study on health benefits of the broccoli Super Sprout - Study on health benefits of the broccoli Super Sprout

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027106
Enrollment
24
Registered
2017-05-01
Start date
2017-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteer

Interventions

Broccoli Super Sprout loading Group (12 cases): Broccoli Super Sprouts 20g/day for 5 days Placebo Group (12 cases): Alfalfa 20g/day for 5 days

Sponsors

Tokai University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Males and females who are 35 to 65 age. 2. Person who are not applicable on the following exclusion criteria. 3. Person who receive adequate explanation for participation in this research and provide written informed consent by their own free will.

Exclusion criteria

Exclusion criteria: We will exclude subjects 1. who are taking medicine regularly with some kind of diseases. 2. with viral hepatitis 3. with serious heart problems 4. with renal dysfunction (serum creatinine > 2.0 mg/dL) 5. with tumor bearing. 6. without capacity of self- management of proper intake and storage on test food. 7. with serious diseases in their life and then judged unsuitable for this study 8. with risk of allergy in associate with this study. 9. With suspected acute infectious diseases which have symptoms such as fever, sore throat, cough, diarrhea, vomiting etc. 10. who participated in other clinical trials within 2 months. 11. Who are taking medicines or supplement thought to affect this study. 12. Who ingested other cruciferous vegetables within 7 days before study day. 13. Who are judged unsuitable for this study by principal investigator and/ or sub-investigator at the collaborative research institution (Shinanozaka Clinic)

Design outcomes

Primary

MeasureTime frame
8-OHdG production rate

Secondary

MeasureTime frame
As secondary endpoints, following items will be evaluated: physical parameters, subjective scores of quality of life, Questions about subjective feelings of fatigue, glycometabolism, physical and mental stress, liver function, serum lipid

Countries

Japan

Contacts

Public ContactYasuhiro Nishizaki

Tokai University School of Medicine Dept. of Clinical Health Science

y-nishizaki@tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026